Daily Hampshire Gazette1dOpinion
Columnist Dr. David Gottsegen: Warning — Trump poses potent risk to health
The week of Jan. 20, 2025, made history in a way few Americans realize. For the first time in 128 years, the Morbidity and ...
Medscape1d
Sitagliptin: An Oral Agent for Glucose Control
Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...
Medicare’s next list of drugs for price negotiation could get ‘very interesting’ — and have a bigger impact on pharma
The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...
PharmiWeb2d
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
Diabetes Drug Market Size to Surpass USD 145 Billion by 2032 at a CAGR of 6.9%, Fueled by Rising Global Diabetes Prevalence – SNS Insider
Global Diabetes Drug Market growth is driven by the rising incidence of diabetes and increasing adoption of innovative treatment solutions.Austin, United States, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ...
Athol Daily News1d
My Turn: Warning — Trump poses potent risk to health
The week of Jan. 20, 2025, made history in a way few Americans realize. For the first time in 128 years, the Morbidity and ...
spoutoff.capemaycountyherald5d
To the spouter who has the 88-year-old neighbor who can't afford
Januvia medication, tell her to ask her doctor to switch this diabetes medication to Tradjenta. The ...